This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Universita Degli Studi Del Piemonte Orientale "Amedeo Avogadro". Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Marta Serafini: Innovator in Lymphohematopoietic Tissue Research
Introduction
Marta Serafini is a notable inventor based in Italy, recognized for her contributions to the field of lymphohematopoietic tissue research. Her work focuses on the use of multipotent adult progenitor cells (MAPCs) and their progeny to populate lymphohematopoietic tissues. This innovative approach has the potential to advance medical treatments related to the lymphohematopoietic system.
Latest Patents
Marta Serafini holds a patent titled "Use Of Mapc Or Progeny Therefrom To Populate Lymphohematopoietic Tissues." This invention relates to the application of MAPCs and their progeny to provide lymphohematopoietic cells in the tissues of the lymphohematopoietic system of a subject. Although she currently has 1 patents, her research is significant in the scientific community.
Career Highlights
Marta Serafini is affiliated with the University of Minnesota, where she engages in groundbreaking research. Her work has the potential to impact various medical fields, particularly in regenerative medicine and cell therapy.
Collaborations
Marta has collaborated with esteemed colleagues, including Catherine M. Verfaillie and Uma Lakshmipathy. These partnerships enhance the depth and breadth of her research, contributing to advancements in the understanding of lymphohematopoietic tissues.
Conclusion
Marta Serafini is an influential inventor whose research on MAPCs is paving the way for future innovations in lymphohematopoietic tissue applications. Her contributions to science and medicine are noteworthy and hold promise for significant advancements in healthcare.